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Abstract 
TRAP1 is anti-apoptotic mitochondrial protein. There have been implications about this chaperone 
and cancer cell metabolism but it is not known how TRAP1 affects. Glutamine synthetase is a 
candidate of TRAP1 binding protein in this study. GS is well known as ammonia detoxifying 
function. This paper will deal with 2 proteins’ binding and their role in cancer cell metabolism. 
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CHAPTER I 
The binding of TRAP1 and GS 
 
I-1. Introduction 
Cancer cell have been under study for a long time. The directions of cancer study are various such as 
cell cycle, apoptosis, and etc discussed by many scientists like Vermeulen (2003) and Shivapurkar 
(2003). One more special point about cancer cell is its metabolism. Cancer cell has different 
respiration mechanism with normal cell. The oxidative phosphorylation after glycolysis is most 
efficient and important energy source in normal cell while it is depressed in cancer cell. Glutamine 
metabolism compensates the ATP production. This is often called ‘Warburg effect’ by Vander Heiden 
(2009). It is caused by several factors. For instance, Building blocks made by glycolysis are essential 
for high proliferating cancer cells. Surroundings of cancer cell has not enough oxygen due to massive 
growth. Function of cancer mitochondria is usually inhibited by cancer genes because mitochondria is 
center of apoptosis as Vander Heiden (2009). Closely related to cancer cell’s characteristic and 
identity, shifted cancer cell metabolism can be a key to understand cancer. 
One of the cancer specific protein is TRAP1 (Tumor necrosis factor-Receptor Associated Protein 1) 
which has undeniable role in cancer cell’s life. It is known to be Heat shock protein 90’s 
mitochondrial homolog, so TRAP1 can act as chaperone according to Felts (2000). It is also known 
that TRAP1 binds to cyclophilin D for inhibiting permeability transition pore on inner membrane, 
which brings out antiapoptotic situation reported by Kang (2007). One more thing is that this protein 
is involved in cancer cell metabolism. A recent paper said that TRAP1 deficient cell had increased 
mitochondrial respiration and decreased glycolysis just as report of Kang (2007). I tried to find the 
metabolic partner of TRAP1 in mitochondria, whose result was Glutamine synthetase (GS). 
Glutamine synthetase, as its name indicates, makes glutamine from glutamate and ammonia with ATP 
consumption. This reaction is usually applied as nitrogen assimilation or ammonia detoxification 
according to Meister (1988). In liver cell, especially, this reaction occurs more than other organs, 
because liver is center of ammonia detoxification just as report of Lobley (1995). According to 
Cadoret (2002), One more interesting thing is that GS is overexpressed in HCC because of β-catenin. 
In this paper, it is talked that GS can be located in cancer cell mitochondria and have possible roles in 
interaction with TRAP1, which might connect GS to cancer cell metabolism. 
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I-2. Materials and Methods. 
 
I-2-1. GST&GST-Recombinant protein expression  
“Vacant or gene cloned pGEX-4T1” transformed BL21 E.coli was cultured with LB 500mL at 37℃ 
and 180 rpm horizontal shaking. When it comes to 0.4∼0.6 of OD600 value, IPTG (isopropyl-β-D-
thogalactopyranoside) was put in to become 0.2mM for inducting GST or GST-fused protein. After 
18℃ overnight induction, E.coli was suspended by 4℃ 3500rpm 15min centrifuge. Resided pellet 
was broken by sonication and cell debris was removed with 4℃ 15000rpm 30min centrifuge. The 
supernatant of centrifuge was fused with Glutathione-sepharose bead for binding. 
 
I-2-2. GST-pull down assay 
GST-bead and GST-TRAP1-bead were settled in open-column. Mitochondrial fraction of mouse brain 
and liver were obtained from 5 weeks old Balb/C strain mouse. All the reactions were done at 4℃ for 
protein stability. Mitochondrial proteins were added to beads with gravity flow. Protein bound beads 
were washed with 20mM HEPES, 2.5mM MgCl2, 75mM KCl, 1M NaCl. Washed beads were then 
analyzed with SDS-PAGE. Suspected protein bands come from silver staining were extracted and had 
In-gel digestion in order to get mass-spectrometry. 
 
I-2-3. Cloning 
Total RNA was obtained from HepG2 by QIAGEN kit. In order to increase total amount of mRNA, 
mRNA purification was left out. Primers surrounding GS gene with EcoRI (5’) and NotI (3’) 
restriction enzyme site were accompanied for Reverse transcription PCR. Other PCRs of vector 
pGEX-4T1 (for protein expression) and pcDNA3 (for in vitro translation) at corresponding restriction 
enzyme sites were also undertaken. Cleaving with each restriction enzyme were done at 37℃ for 3 
hours. Purely cleaved GS gene & vector fragments were purified by agarose-gel extraction. Two 
fragments were ligated at 16℃ for 14hours. Transformation and Mini-prep by GeneAll kit was done 
for confirm whether right plasmids were cloned. Sequencing was done by Macrogen. 
 
I-2-4. Binding assay with in vitro translation 
GST and GST-TRAP1 beads were blocked with 10mg/ml BSA. 2μl of GS cloned pcDNA3 was 
incubated with 2μl of 35S tagged methionine and 22μl of TNT T7 Quick master mix from Promega at 
30℃ for an hour. 10μl of blocked beads were incubated with in vitro 10μl of translated GS, 20μl of 
10mg/ml BSA, and 160μl of HEPES buffer (HEPES 20mM, KCl 75mM, EDTA 0.1mM, NP-40 
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0.05%, and MgCl2 2.5mM) for overnight. Beads were mildly washed with HEPES buffer for 3 times 
and analyzed with SDS-PAGE. After gel running and Coomassie staining are over, gel was dried in 
center of cellophane film in order to stay plain. Dried gel was analyzed for radioactive signals from 
35S by Typhoon 7200. 
 
I-2-5. Mitochondria import assay 
Overall procedure was followed by method of Young (2007). Another 35S tagged protein expressed 
just as in vitro translation while 5 weeks old Balb/C mouse’s liver mitochondria is obtained. 
Expressed protein is incubated at 30℃ for 20 min with mitochondria suspended in MS buffer (250 
mM sucrose, 80 mM Potassium acetate, 20 mM HEPES-KOH [pH 7.5], and 5 mM Magnesium 
chloride). Half of the incubated solution is treated with proteinase K to become 50μg/ml at 4℃ for 1 
min in order to remove unimported proteins. After washing the mitochondria with MS buffer once, 
SDS-PAGE was done and gel was analyzed for radioactive signals from 35S by Typhoon 7200. 
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I-3. Results. 
 
 
 
 
 
 
 
←∼42kDa  
←∼38kDa 
←∼26kDa 
 
Fig 1. GST-pull down assay of TRAP1. GST-bead + Liver, GST-TRAP1 bead, GST-TRAP1 bead + brain 
mitochondria, and GST-TRAP1 bead +  liver mitochondria from left to right 
Description ΣCoverage 
Glutamine synthetase 
OS=Mus musculus GN=Glul PE=1 SV=6 - [GLNA_MOUSE] 
21.98 
Actin-related protein 2 
OS=Mus musculus GN=Actr2 PE=1 SV=1 - [ARP2_MOUSE] 
19.29 
Septin-5 
OS=Mus musculus GN=Sept5 PE=1 SV=2 - [SEPT5_MOUSE] 
19.24 
Serpin B6 
OS=Mus musculus GN=Serpinb6 PE=2 SV=1 - [SPB6_MOUSE] 
11.64 
Ganglioside-induced differentiation-associated protein 1-like 1 
OS=Mus musculus GN=Gdap1l1 PE=2 SV=1 - [Q3USC7_MOUSE] 
10.08 
Mitogen-activated protein kinase 1 
OS=Mus musculus GN=Mapk1 PE=1 SV=3 - [MK01_MOUSE] 
9.78 
 
Table 1. Highest ΣCoverage valued part of Mass spectrometry result. ΣCoverage is an estimated value summarized of 
‘amount of covered sequence by found-peptides’, ‘confidency in peptide matching”, and ‘no existence in control 
band’. Glutamine synthetase was selected as a significant result from overall suspect proteins.  
 
 
Figure 2. Mouse GS sequence covered by identified peptides from mass analysis 
Fig 1 shows 3 bands in liver mitochondria column which was not shown in brain. After the mass 
spectrometry, GS, at the ~42kDa band, was the most significant candidate because of relativity in 
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metabolism and cancer. The coverage of GS is shown in Fig 2. 
 
  
A. B 
C  
Fig 3. Binding assay with in vitro translation. A. Coomassie staining image. B. Detection of 35S-Methionine Each column 
means (35S-Methionine GS)-(vacant)-(GS + GST-bead)-(GS + GST-TRAP1 bead) from left to right. C is detection of 35S 
radioactivity of (35S-Methionine TRAP1) - (TRAP1 + GST-bead) - (TRAP1 + GST-GS bead) 
 
A.  1     2     3 B.  1     2     3 C.  1     2     3 D.  1     2     3 
Fig 4. Mitochondrial import assay. A. OTC(Tom 20), B. PiC(Tom70), C. GS, and D. GS with cytosolic fraction. 1 is 
protein itself, 2 is protein with mitochondria, and 3 is PK treated sample of protein with mitochondria. 
 
In vitro translation in Fig 3 showed that GS directly binds to GST-TRAP1 much more than GST while 
actual amount of GST-TRAP1 bead is rather less than that of GST bead. This confirms the actual 
binding of GS and TRAP1 in vitro. But binding of TRAP1 with GST-GS was not seen. This 
difference will be discussed later. 
Mitochondrial import assay in Fig 4 did not show the import of GS and positive control of Tom20, 
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OTC (Ornithine tramscarbamoylase), according to Takanori (2001), into mouse normal liver 
mitochondria while positive control of Tom70, PiC (Phosphate carrier protein), reported by Young 
(2007), exhibited typical MTS-cleaving import. The additional experiment incubating cytosolic 
fraction together was also done but, as you can see in Fig 3, there was no difference in result. 
 
I-4. Discussion 
 
We can see that TRAP1 directly binds to GS in vitro. It is interesting that GS binds to GST-TRAP1 
while TRAP1 doesn’t bind to GST-GS. We can make 2 assumptions. One is that N-terminal sequence 
of GS is necessary for binding. TRAP1 in this case would act as a mitochondrial guidance or setting 
localization as N-terminal sequence of GS can be used as targeting sequence. This hypothesis can be 
supported by fact that cytosolic HSP70 and 90 guides protein to mitochondria. Another assumption is 
based on GS’ homopolymer. GS is known for polymerized in vivo at active state. So it can be 
assumed that TRAP1 only binds to polymerized form of GS. This case can deduce that binding 
between TRAP1 and GS is related to GS activity. These hypotheses can be solved by in vivo binding, 
Knock-out study and activity assay. 
The import of GS into normal liver cell mitochondria could not be seen. The murine mitochondria 
might not import human OTC and GS. As weak mitochondrial targeting sequence of GS is at N-
terminal, GS seems to be imported through Tom20 according to Brix (1999). Human cell 
mitochondria should be checked through this import assay. 
 
B. 
A.  
Fig 5. Similarity in amino acid sequence of Human and chicken. A is whole amino acid sequence. B is N-terminal region 
 
There are some indications that GS might get into cancer mitochondria. As reported by Matthews 
(2009), uricotelic species’ liver has mitochondrial GS due to their higher mitochondrial membrane 
potential. It is known that cancer cell’s mitochondrial membrane potential is higher than that of 
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normal cell’s because of lacking oxidative phosphorylation. Moreover, uricotelic GS’ N-terminal has 
“weak” mitochondrial targeting sequence. The 23 amino acids at N-terminal for human and chicken 
has 73.9% similarity. The most important difference is that 19th amino acid is positive in chicken’s 
while not in human’s. As positive charge is important for mitochondrial import, this might be 
significant change.  
 
  
A. B. 
Fig 6. 2 points of view of TRAP1 and GS binding in mitochondria. A. is GS involved in Ammonia detoxification. B. is 
about glutamine metabolism related to energy production.  
 
There is another significant thing in GS and HCC. C3A and HepG2, both of them are HCC, have little 
or no expression of urea cycle enzyme reported by Mavri‐Damelin (2008). As a result, those cells 
could not detoxify ammonia while normal hepatocytes could. As GS and GLT-1, glutamate uptake 
protein, according to Cadoret (2002), is overexpressed in HCC, glutamine production could be 
alternative ammonia detoxification with harvested glutamate from outside of cell and highly 
expressed GS, even though ATP is consumed. This newly made glutamine can be nitrogen source for 
protein, nucleotides, and etc discovered by Rajagopalan and DeBerardinis (2011). In this situation, GS 
has another reason for getting into mitochondria because ammonia is usually made in mitochondria. 
So GS had better get into mitochondria to detoxify efficiently. TRAP1, the antiapoptotic protein of 
cancer cell, would help GS’ activity somehow if import of GS is for ammonia detoxification. 
But there is another possibility. Glutamine metabolism initiated by making glutamate from glutamine 
would be bothered if GS go into mitochondria. Even though GS’ reaction and ‘will’ is detoxification 
of ammonia, returning glutamate back to glutamine can be inhibition of glutamine metabolism’s first 
stage. TRAP1’s binding should be inhibition of GS activity in this manner. The activity assay of GS 
with and without TRAP1 should be done to confirm whether GS is inhibited or activated by TRAP1. 
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